Crystal Structure of Medicinal Product Triazavirin

被引：6
|
作者：
Voinkov, E. K. [1 ]
Drokin, R. A. [1 ]
Ulomskiy, E. N. [1 ,2 ]
Slepukhin, P. A. [2 ]
Rusinov, V. L. [1 ,2 ]
Chupakhin, O. N. [1 ,2 ]
机构：
[1] Ural Fed Univ, Dept Organ & Biomol Chem, 19 Mira St, Ekaterinburg 620002, Russia
[2] RAS, Inst Organ Synth, Ural Div, 22-20 S Kovalevskoy St,Akad Skaya St, Ekaterinburg 620990, Russia
来源：
JOURNAL OF CHEMICAL CRYSTALLOGRAPHY | 2019年 / 49卷 / 04期
基金：
俄罗斯科学基金会;
关键词：
Triazavirin; Antiviral; Triazolotriazine; Drug; Thermogravimetry; PROPHYLACTIC EFFICACY; INFLUENZA-VIRUS; ENCEPHALITIS;
D O I：
10.1007/s10870-018-0750-2
中图分类号：
O7 [晶体学];
学科分类号：
0702 ; 070205 ; 0703 ; 080501 ;
摘要：
The X-ray data of 2-methylsulfanyl-6-nitro-1,2,4-triazolo [5,1-c][1,2,4]triazin-7-one sodium salt dihydrate (triazavirin) is reported. The compound crystallizes in the form binuclear complex ?? triclinic space group P-1 with unit cell parameters: a=7.2616 (6) angstrom, b=9.3036 (5) angstrom, c=9.5237 (7) angstrom, alpha=110.968 (6), beta=92.600 (6)degrees, gamma=102.990 (6)degrees and Z=1. [GRAPHICS] . Graphical AbstractInteraction of 3-(methylsulfanyl)-1H-1,2,4-triazole-5-diazonium hydrochloride with ethyl nitroacetate in sodium carbonate solution resulted in the formation of centrosymmetric binuclear complex of 2-methylsulfanyl-6-nitro-1,2,4-triazolo[5,1-c][1,2,4]triazin-7-one sodium salt dihydrate (triazavirin), which was structurally characterized.
引用
收藏
页码：213 / 218
页数：6
相关论文
共 50 条
  • [41] QUANTITATION OF PIRACETAM AND CINNARIZINE IN A COMBINED MEDICINAL PRODUCT
    Bardarov, V.
    Zikolova, T.
    Radoevska, N.
    Sahtura, A.
    PHARMACIA, 2008, 55 (1-4) : 14 - 17
  • [42] Biosynthetic medicinal chemistry of natural product drugs
    Koehn, Frank E.
    MEDCHEMCOMM, 2012, 3 (08) : 854 - 865
  • [43] On approach for prognosis of dissolution of a medicinal product in an organism
    Pankratov, E. L.
    INNOVATION AND EMERGING TECHNOLOGIES, 2024, 11
  • [44] Software support in automation of medicinal product evaluations
    Juric, R
    Shojanoori, R
    Slevin, L
    Williams, S
    Medical and Care Compunetics 2, 2005, 114 : 298 - 306
  • [45] Medicinal Product Regulation: Portugal's Framework
    Herdeiro, Maria Teresa
    Bastos, Paulo D.
    Teixeira-Rodrigues, Antonio
    Roque, Fatima
    CLINICAL THERAPEUTICS, 2016, 38 (09) : 2118 - 2126
  • [46] Experimental Product Testing of biomedical Medicinal Products
    Vieths, S.
    Seitz, R.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2014, 57 (10) : 1131 - 1132
  • [47] THE USE OF SINGLE-CRYSTAL X-RAY STRUCTURE-ANALYSIS IN MEDICINAL CHEMISTRY
    DEJOODE, MDV
    ZEELEN, FJ
    RECUEIL DES TRAVAUX CHIMIQUES DES PAYS-BAS-JOURNAL OF THE ROYAL NETHERLANDS CHEMICAL SOCIETY, 1982, 101 (03): : 81 - 84
  • [48] Crystal structure of the polyketide cyclase AknH with bound substrate and product analogue:: Implications for catalytic mechanism and product stereoselectivity
    Kallio, P
    Sultana, A
    Niemi, J
    Mäntsälä, P
    Schneider, G
    JOURNAL OF MOLECULAR BIOLOGY, 2006, 357 (01) : 210 - 220
  • [49] Crystal structure of dimeric Synechococcus spermidine synthase with bound polyamine substrate and product
    Guedez, Gabriela
    Pothipongsa, Apiradee
    Siren, Saija
    Liljeblad, Arto
    Jantaro, Saowarath
    Incharoensakdi, Aran
    Salminen, Tiina A.
    BIOCHEMICAL JOURNAL, 2019, 476 : 1009 - 1020
  • [50] INTERACTION OF CEMBRENE WITH N-BROMSUCCINIMIDE - CRYSTAL-STRUCTURE OF CYCLIZATION PRODUCT
    GATILOV, YV
    BAGRJANSKA, IY
    YAROSHENKO, NI
    RALDUGIN, VA
    KHIMIYA PRIRODNYKH SOEDINENII, 1983, (05): : 651 - 652
12345